Taking the lessons of the previous sessions, this program will explore the types of civil, investigative, and regulatory proceedings that can be brought against managers and executives in the life sciences industry, the risks associated with those proceedings, and the use of insurance to manage and mitigate risks.
Specific topics will include:
- Securities, derivative, and private litigation against life sciences industry executives
- Regulatory investigations and proceedings, including new HHS-OIG guidance on Permissive Exclusion Authority
- E-discovery and other litigation costs
- D&O insurance and other types of insurance that may be available
Register for the live event. Registration and lunch will begin at 12:00 p.m.
Register for the webinar. The presentation will begin at 12:30 p.m.
About the Philadelphia Life Sciences Seminar Series
This series of five interdisciplinary live seminars, scheduled to take place from July through December, is focused on the life sciences sector and hosted by Hogan Lovells lawyers in the FDA, Corporate, and Litigation/White Collar groups. The series will focus on regulatory and enforcement updates and will discuss the significance of these changes to advisory obligations.
Each 60-minute seminar will address distinct developments in regulatory SEC, FDA, and HHS-OIG oversight and enforcement and will include a Q&A session at the end to address your specific concerns.